Brett Nanigian - 03 Feb 2022 Form 3 Insider Report for AutoWeb, Inc.

Role: SVP, Product & Technology
Signature: /s/ Glenn E. Fuller, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 03 Feb 2022
Net transactions value: $0
Form type: 3
Filing time: 11 Feb 2022, 16:40:24 UTC
Next filing: 02 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AUTO	Common Stock						6,400	03 Feb 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	AUTO	Employee Stock Options (Right to Buy)							03 Feb 2022	Common Stock	30,000	$3.30	Direct	F1
holding	AUTO	Employee Stock Options (Right to Buy)							03 Feb 2022	Common Stock	30,000	$2.00	Direct	F2
holding	AUTO	Employee Stock Options (Right to Buy)							03 Feb 2022	Common Stock	30,000	$2.57	Direct	F3
holding	AUTO	Employee Stock Options (Right to Buy)							03 Feb 2022	Common Stock	25,000	$2.63	Direct	F4
holding	AUTO	Employee Stock Option (Right to Buy)							03 Feb 2022	Common Stock	65,000	$2.79	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant on April 17, 2019, to reporting person of options to buy shares of common stock in transaction exempt under Rule 16b-3. These options will become vested and exercisable as follows: (i) 33 1/3% (adjusted to avoid the vesting of fractional options) vested and became exercisable on April 17, 2020, and (ii) 1/36 (adjusted monthly to avoid the vesting of fractional options in any month) shall vest and become exercisable on each successive monthly anniversary thereafter for the following 24 months ending April 17, 2022.
F2	Grant on February 26, 2020, to reporting person of options to buy shares of common stock in transaction exempt under Rule 16b-3. These options will become vested and exercisable as follows: (i) 33 1/3% (adjusted to avoid the vesting of fractional options) vested and became exercisable on February 26, 2021, and (ii) 1/36 (adjusted monthly to avoid the vesting of fractional options in any month) shall vest and become exercisable on each successive monthly anniversary thereafter for the following 24 months ending February 26, 2023.
F3	Grant on February 26, 2021, to reporting person of options to buy shares of common stock in transaction exempt under Rule 16b-3. These options will become vested and exercisable as follows: (i) 33 1/3% (adjusted to avoid the vesting of fractional options) shall vest and become exercisable on February 26, 2022, and (ii) 1/36 (adjusted monthly to avoid the vesting of fractional options in any month) shall vest and become exercisable on each successive monthly anniversary thereafter for the following 24 months ending February 26, 2024.
F4	Grant on August 25, 2021, to reporting person of options to buy shares of common stock in transaction exempt under Rule 16b-3. These options will become vested and exercisable as follows: (i) 33 1/3% (adjusted to avoid the vesting of fractional options) shall vest and become exercisable on August 25, 2022, and (ii) 1/36 (adjusted monthly to avoid the vesting of fractional options in any month) shall vest and become exercisable on each successive monthly anniversary thereafter for the following 24 months ending August 25, 2024.
F5	Grant on February 3, 2022, to reporting person of options to buy shares of common stock in transaction exempt under Rule 16b-3. These options will become vested and exercisable as follows: (i) 33 1/3% (adjusted to avoid the vesting of fractional options) shall vest and become exercisable on February 3, 2023, and (ii) 1/36 (adjusted monthly to avoid the vesting of fractional options in any month) shall vest and become exercisable on each successive monthly anniversary thereafter for the following 24 months ending February 3, 2025.